📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers. (2016)

First Author: Meeks HD

Attributed to: Glasgow Molecular Pathology (GMP) Node funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/jnci/djv315

PubMed Identifier: 26586665

Publication URI: http://europepmc.org/abstract/MED/26586665

Type: Journal Article/Review

Volume: 108

Parent Publication: Journal of the National Cancer Institute

Issue: 2

ISSN: 0027-8874